Skip to main content
SpringerLink
Log in

Thyroid Disorders and Hormonal Contraceptives

  • Chapter
  • First Online:
Thyroid Diseases in Pregnancy

  • 438 Accesses

Abstract

Thyroid dysfunction is a common endocrine disorder among reproductive-aged women, the groups of women who most commonly use effective hormonal contraceptives (HCs) for both spacing and limiting births. However, HCs including either combined estrogen-progestin or progestin-only contraceptives and thyroid hormones have profound interactions to each other. Although women with no thyroid disease adapt quickly to thyroid hormonal alterations induced by those agents, those small alterations may be clinically important for women who suffer from thyroid disorders. Similarly, there are limited studies suggesting that thyroid hormones may affect the action of estrogen and subsequently can affect the efficacy and safety of HCs. This chapter focuses on the various aspects of interaction between thyroid hormones and HCs in order to present the clinical guide for daily practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hall KS, White KOC, Reame N, Westhoff C. Studying the use of oral contraception: a review of measurement approaches. J Womens Health (Larchmt). 2010;19(12):2203–10.

    Article  Google Scholar 

  2. Sitruk-Ware R, Nath A, Mishell DR Jr. Contraception technology: past, present and future. Contraception. 2013;87(3):319–30.

    Article  PubMed  Google Scholar 

  3. Dinger J, Do Minh T, Buttmann N, Bardenheuer K. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol. 2011;117(1):33–40.

    Article  CAS  PubMed  Google Scholar 

  4. Brynhildsen J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther Adv Drug Saf. 2014;5(5):201–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Benagiano G, Carrara S, Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Prefer Adherence. 2009;3:131–43.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Stewart M, Black K. Choosing a combined oral contraceptive pill. Aust Prescr. 2015;38(1):6–11.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kelekci KH, Kelekci S, Yengel I, Gul S, Yilmaz B. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens. J Dermatolog Treat. 2012;23(3):177–83.

    Article  CAS  PubMed  Google Scholar 

  8. Bastianelli C, Farris M, Rosato E, Brosens I, Benagiano G. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation. Expert Rev Clin Pharmacol. 2018;11(11):1085–98.

    Article  CAS  PubMed  Google Scholar 

  9. Sober SP, Schreiber CA. Controversies in family planning: are all oral contraceptive formulations created equal? Contraception. 2011;83(5):394–6.

    Article  PubMed  Google Scholar 

  10. Erkkola R, Landgren BM. Role of progestins in contraception. Acta Obstet Gynecol Scand. 2005;84(3):207–16.

    Article  PubMed  Google Scholar 

  11. Torre F, Calogero AE, Condorelli RA, Cannarella R, Aversa A, La Vignera S. Effects of oral contraceptives on thyroid function and vice versa. J Endocrinol Invest. 2020;43(9):1181–8.

    Article  CAS  PubMed  Google Scholar 

  12. Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–31.

    Article  PubMed  CAS  Google Scholar 

  13. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol. 2007;66(3):309–21.

    Article  CAS  Google Scholar 

  14. Panth P, Guerin G, DiMarco NM. A review of iodine status of women of reproductive age in the USA. Biol Trace Elem Res. 2019;188(1):208–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mintziori G, Anagnostis P, Toulis KA, Goulis DG. Thyroid diseases and female reproduction. Minerva Med. 2012;103(1):47–62.

    CAS  PubMed  Google Scholar 

  16. Aghajanova L, Lindeberg M, Carlsson IB, Stavreus-Evers A, Zhang P, Scott JE, et al. Receptors for thyroid-stimulating hormone and thyroid hormones in human ovarian tissue. Reprod Biomed Online. 2009;18(3):337–47.

    Article  CAS  PubMed  Google Scholar 

  17. Tahboub R, Arafah BM. Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23(6):769–80.

    Article  CAS  PubMed  Google Scholar 

  18. Kester MH, van Dijk CH, Tibboel D, Hood AM, Rose NJ, Meinl W, et al. Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab. 1999;84(7):2577–80.

    Article  CAS  PubMed  Google Scholar 

  19. Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011;2011:875125.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Sänger N, Stahlberg S, Manthey T, Mittmann K, Mellinger U, Lange E, et al. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use. Contraception. 2008;77(6):420–5.

    Article  PubMed  CAS  Google Scholar 

  21. Coussa A, Hasan HA, Barber TM. Impact of contraception and IVF hormones on metabolic, endocrine, and inflammatory status. J Assist Reprod Genet. 2020;37(6):1267–72.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sitruk-Ware R, Plu-Bureau G, Menard J, Conard J, Kumar S, Thalabard JC, et al. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study. J Clin Endocrinol Metab. 2007;92(6):2074–9.

    Article  CAS  PubMed  Google Scholar 

  23. Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93(5):1702–10.

    Article  CAS  PubMed  Google Scholar 

  24. Shifren JL, Desindes S, McIlwain M, Doros G, Mazer NA. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause. 2007;14(6):985–94.

    Article  PubMed  Google Scholar 

  25. Dickson RB, Eisenfeld AJ. 17 alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells. Endocrinology. 1981;108(4):1511–8.

    Article  CAS  PubMed  Google Scholar 

  26. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743–9.

    Article  CAS  PubMed  Google Scholar 

  27. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, et al. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters. Contraception. 2003;67(5):361–6.

    Article  CAS  PubMed  Google Scholar 

  28. Loriaux DL, Wild RA. Contraceptive choices for women with endocrine complications. Am J Obstet Gynecol. 1993;168(6 Pt 2):2021–6.

    Article  CAS  PubMed  Google Scholar 

  29. Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer WF, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care. 2011;16(6):458–67.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Bisschop PH, Toorians AW, Endert E, Wiersinga WM, Gooren LJ, Fliers E. The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals. Eur J Endocrinol. 2006;155(1):11–6.

    Article  CAS  PubMed  Google Scholar 

  31. Quintino-Moro A, Zantut-Wittmann DE, Silva Dos Santos PN, Melhado-Kimura V, da Silva CA, Bahamondes L, et al. Thyroid function during the first year of use of the injectable contraceptive depot medroxyprogesterone acetate. Eur J Contracept Reprod Health Care. 2019;24(2):102–8.

    Article  CAS  PubMed  Google Scholar 

  32. Sathi P, Kalyan S, Hitchcock CL, Pudek M, Prior JC. Progesterone therapy increases free thyroxine levels—data from a randomized placebo-controlled 12-week hot flush trial. Clin Endocrinol. 2013;79(2):282–7.

    Article  CAS  Google Scholar 

  33. Alexopoulou O, Beguin C, De Nayer P, Maiter D. Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol. 2004;150(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  34. Li H, Li J. Thyroid disorders in women. Minerva Med. 2015;106(2):109–14.

    CAS  PubMed  Google Scholar 

  35. Behboudi-Gandevani S, Ramezani Tehrani F, Cheraghi L, Noroozzadeh M, Farahmand M, Azizi F. Trends of contraception use among married reproductive age women: Tehran lipid and glucose cohort study 2002-2011. Sex Reprod Healthc. 2017;12:116–22.

    Article  PubMed  Google Scholar 

  36. Jarosz AC, Jamnik J, El-Sohemy A. Hormonal contraceptive use and prevalence of premenstrual symptoms in a multiethnic Canadian population. BMC Womens Health. 2017;17(1):87.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Vasudevan N, Ogawa S, Pfaff D. Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev. 2002;82(4):923–44.

    Article  CAS  PubMed  Google Scholar 

  38. Zhou M, Wang M, Li J, Luo X, Lei M. Effects of thyroid diseases on pregnancy outcomes. Exp Ther Med. 2019;18(3):1807–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Ramezani Tehrani F, Nazarpour S, Behboudi-Gandevani S. Isolated maternal hypothyroxinemia and adverse pregnancy outcomes: a systematic review. J Gynecol Obstet Hum Reprod. 2021;50(7):102057.

    Article  PubMed  Google Scholar 

  40. Ge GM, Leung MTY, Man KKC, Leung WC, Ip P, Li GHY, et al. Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020;105(12):dgaa555.

    Article  PubMed  Google Scholar 

  41. Sun X, Hou N, Wang H, Ma L, Sun J, Liu Y. A meta-analysis of pregnancy outcomes with levothyroxine treatment in euthyroid women with thyroid autoimmunity. J Clin Endocrinol Metab. 2020;105(4):dgz217.

    PubMed  Google Scholar 

  42. Knudsen N, Bülow I, Laurberg P, Perrild H, Ovesen L, Jørgensen T. Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol. 2002;57(1):71–6.

    Article  CAS  Google Scholar 

  43. Furlanetto TW, Nguyen LQ, Jameson JL. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology. 1999;140(12):5705–11.

    Article  CAS  PubMed  Google Scholar 

  44. Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system—a spotlight on the role of progestogens. Autoimmun Rev. 2015;14(6):536–42.

    Article  CAS  PubMed  Google Scholar 

  45. Williams WV. Hormonal contraception and the development of autoimmunity: a review of the literature. Linacre Q. 2017;84(3):275–95.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Cutolo M, Brizzolara R, Atzeni F, Capellino S, Straub RH, Puttini PC. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci. 2010;1193:36–42.

    Article  CAS  PubMed  Google Scholar 

  47. Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Fröhlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347–69.

    Article  CAS  PubMed  Google Scholar 

  50. Michel KG, Huijbregts RPH, Gleason JL, Richter HE, Hel Z. Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract. J Acquir Immune Defic Syndr. 2015;68(5):511–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Soria-Jasso LE, Cariño-Cortés R, Muñoz-Pérez VM, Pérez-Hernández E, Pérez-Hernández N, Fernández-Martínez E. Beneficial and deleterious effects of female sex hormones, Oral contraceptives, and phytoestrogens by immunomodulation on the liver. Int J Mol Sci. 2019;20(19):4694.

    Article  CAS  PubMed Central  Google Scholar 

  52. Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B. The relationship between circulating estradiol and thyroid autoimmunity in males. Eur J Endocrinol. 2014;170(1):63–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Nursing and Health Sciences, Nord University, Bodø, Norway

    Samira Behboudi-Gandevani

Authors
  1. Samira Behboudi-Gandevani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samira Behboudi-Gandevani .

Editor information

Editors and Affiliations

  1. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Fereidoun Azizi

  2. Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Fahimeh Ramezani Tehrani

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Behboudi-Gandevani, S. (2022). Thyroid Disorders and Hormonal Contraceptives. In: Azizi, F., Ramezani Tehrani, F. (eds) Thyroid Diseases in Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-030-98777-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-98777-0_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-98776-3

  • Online ISBN: 978-3-030-98777-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation